消息

SMX's verification technology is poised to capitalize on the emerging trend of certified recycled plastic becoming economically competitive with virgin oil‑derived plastic. As the global economy shifts towards a more circular model, where materials are kept in use for as long as possible through recovery, reuse, and recycling, SMX's molecular marki...

全文

RBB's lead candidate, RB‑190, has demonstrated reversal of key disease pathologies in preclinical models and multiple published studies, supporting advancement into Phase 2 clinical development. The company's founder and CEO, Jonathan Sackner‑Bernstein, expressed enthusiasm for the partnership, highlighting its potential to accelerate the developme...

全文

The collaboration with Dassault Systèmes' global ecosystem of scientific, engineering, and regulatory expertise will provide RBB with the resources needed to execute efficiently, generate high-quality data, and position the company for strategic partnerships and future financing. This is particularly important as RBB prepares to advance its therapy...

全文

Right Brain Bio, Inc. (RBB) has been selected to participate in the Dassault Systèmes 3DEXPERIENCE Lab startup accelerator program. This selection provides RBB with access to the MEDIDATA clinical trial platform, which will enable the company to streamline trial execution and deliver high-quality results faster. The partnership is expected to benef...

全文

Investors should be aware of the risks involved with leveraging products like TQQQ. While they may generate impressive returns during bull markets, they can also amplify losses in downturns or periods of volatility. A successful long‑term investing strategy typically involves steady compounding over time, rather than relying on tripled market moves...

全文

However, this strategy can backfire in volatile markets, accelerating losses as much as gains. Yesterday's sell‑off serves as a reminder that leverage works both ways: while SOXL lost 23 % in a single session, TQQQ would have lost approximately 3 %. The article warns that leveraged ETFs are designed for traders, not investors, and their daily rebal...

全文

TQQQ's assets have nearly doubled to approximately $40 billion since April, contributing to a record $198 billion total U.S. leveraged ETF assets. This surge is driven by investor demand for amplified returns from popular sectors, particularly technology and semiconductors. Leveraged ETFs like TQQQ aim to deliver three times the daily return of the...

全文

Sellas Life Sciences (NASDAQ: SLS) is listed among the top 10 stocks on social‑media platforms that are expected to 10× in value, according to a Yahoo Finance article. The company backs a cancer immunotherapy called GPS, which teaches patients’ immune systems to target malignant cells. GPS is being evaluated in the REGAL trial for acute myeloid leu...

全文

The announcement also notes that the offer of these securities is not directed at persons in the United States or any jurisdiction where such distribution would be unlawful. The securities have not been registered under the US Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registr...

全文

CLARIANE SE, a guarantor-issuing company, has announced a pre‑stabilization period for its issuance of EUR 333M PERP UNDATED NC3 SUBORDINATED FIXED RATE RESETTABLE NOTES. BNP Paribas, as Stabilisation Coordinator, has notified the potential stabilisation of these securities in accordance with Commission Delegated Regulation EU/2016/1052 under the M...

全文